LeonaBio, Inc. (LONA) — Financial statements
Income statement, balance sheet, and cash flow for LeonaBio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 68 | 0.00 | 0.00 | 0.00↓100.0% | 0.48 | |
| Gross Profit | -68 | 0.00 | 0.00 | 0.00↑100.0% | -0.48 | |
| Operating Expenses | ||||||
| R&D Expenses | 18↓75.2% | 71↓24.6% | 94↑52.6% | 61↑43.6% | 43 | |
| General & Administrative Expenses | 17↓36.1% | 26↓21.7% | 33↑2.3% | 33↑53.3% | 21 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 17↓36.1% | 26↓21.7% | 33↑2.3% | 33↑53.3% | 21 | |
| Other Expenses | 0.00↓100.0% | 4↑353.5% | -2↓116.3% | 10↑2187.7% | -0.48 | |
| Operating Expenses | 34↓66.1% | 101↓19.6% | 125↑20.6% | 104↑63.7% | 64 | |
| Total Costs & Expenses | 102↑1.4% | 101↓19.6% | 125↑20.6% | 104↑62.5% | 64 | |
| Operating Results | ||||||
| Operating Income | -102↓1.4% | -101↑19.6% | -125↓20.6% | -104↓62.5% | -64 | |
| Depreciation & Amortization | 0.00↓100.0% | 0.97↑0.1% | 0.97↑14.7% | 0.85↑76.4% | 0.48 | |
| EBITDA | -102↓6.7% | -96↑23.9% | -126↓43.1% | -88↓61.9% | -54 | |
| EBIT | -102↓5.7% | -97↑23.8% | -127↓42.9% | -89↓62.0% | -55 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↓100.0% | 4↓48.1% | 8↑136.2% | -21↓6417.4% | 0.33 | |
| Interest Income | 0.00↓100.0% | 4↓48.1% | 8↑137.5% | 3↑854.3% | 0.34 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 24↑810433.3% | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -4↓380.6% | 1↑109.7% | -15↓65.3% | -9 | |
| Other Income / Expenses | -3↓184.4% | 4↓49.2% | 8↓7.0% | 8↓8.6% | 9 | |
| Income Before Tax | -106↓8.9% | -97↑17.6% | -118↓23.0% | -96↓74.4% | -55 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -106↓8.9% | -97↑17.6% | -118↓23.0% | -96↓74.4% | -55 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -106↓8.9% | -97↑17.6% | -118↓23.0% | -96↓74.4% | -55 | |
| Bottom-Line Net Income | -106↓8.9% | -97↑17.6% | -118↓23.0% | -96↓74.4% | -55 | |
| EPS (Basic) | -24.70↑2.0% | -25.20↑18.4% | -30.90↓22.1% | -25.30↓69.8% | -14.90 | |
| EPS (Diluted) | -24.70↑2.0% | -25.20↑18.4% | -30.90↓22.1% | -25.30↓69.8% | -14.90 | |
| Weighted Average Shares | 4↑11.1% | 4↑1.2% | 4↑0.8% | 4↑2.2% | 4 | |
| Weighted Average Diluted Shares | 4↑11.1% | 4↑1.2% | 4↑0.8% | 4↑2.2% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.